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Acronyms  
AIDS  Acquired immunodeficiency syndrome 
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RH   Reproductive health 
STI   Sexually transmitted infection 
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WHO   World Health Organization 
1 
 
Executive summary 
Female condoms are an important option for dual protection from unintended pregnancy and HIV and 
other sexually transmitted infections, especially when male condoms cannot be used. Incorporating 
female condoms into other HIV prevention channels is a potential strategy to increase access for women 
and men in need of dual protection beyond male condoms. Policies recommend incorporating female 
condoms into two HIV prevention programs that have gained significant momentum and political 
support—prevention of mother-to-child transmission of HIV (PMTCT) and voluntary medical male 
circumcision (VMMC). However, there is a lack of clarity on how female condoms are being included at 
the programmatic level.  
PATH undertook a qualitative assessment in Kenya to explore the opportunities and challenges to 
integrate female condoms in PMTCT and VMMC programs and identify strategies to help improve 
integration and access in future programming. PATH selected Kenya because it offers a plausible 
environment for integration, which includes established PMTCT and VMMC programs, supportive 
national policies and guidelines, some female condom distribution, and significant health needs. 
PATH employed qualitative methods to collect and analyze data. Desk research was performed to 
understand the PMTCT and VMMC landscape in Kenya and to inform purposive sampling of 
stakeholders. Ethics approval was received from the Kenya National Commission for Science, 
Technology, and Innovation. PATH then conducted 17 face-to-face interviews with policymakers, 
international aid officials, service providers, and advocates in Nairobi and Nyanza areas. PATH had 
obtained each stakeholder’s verbal consent to be interviewed during the scheduling process. Interviews 
were conducted in English and lasted approximately 60 minutes. For data analysis, PATH staff examined 
interview notes and performed manual coding for themes.  
The stakeholder interviews confirmed that female condoms are not typically available for distribution at 
PMTCT and VMMC sites in Kenya. All stakeholders were familiar with the product, however, and most 
thought that it offered numerous advantages as a woman-initiated dual protection method. Integrating 
female condoms into PMTCT and VMMC programs was believed to be feasible because policies, 
training, and distribution systems that can support product inclusion are already in place. Stakeholders 
reported that female condoms are included in counselor training curriculums and that the supply chain is 
the same as for male condoms. The barriers to integration that were cited were similar to those facing 
female condom programming generally.  
The foremost challenge is the absence of female condoms in public-sector health facilities or retail 
channels; integration cannot happen without the product itself. Many stakeholders pointed to the 
relatively high cost of female condom commodities to the national government—particularly when 
compared with male condoms—as a main driver of low availability in the public-sector. Stakeholders 
identified additional barriers at the individual, facility, and government levels that contribute to the lack 
of product availability. These barriers largely involve negative attitudes and misperceptions that stymie 
demand creation and discourage government officials from recognizing female condoms as a critical 
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commodity. Stakeholders offered many insights into how to address these barriers so that female 
condoms could be a valuable and viable offering in PMTCT and VMMC programs.    
 
 
 
Barriers and recommended actions to improve female condom integration 
Individual level 
Barrier 1: Low awareness among women and men 
Recommended action: Leverage VMMC programs as an untapped platform to reach men and their 
female family members with female condom promotion. 
Barrier 2: Product misperceptions and resistance among men 
Recommended action: Take advantage of the couples-counseling setting in PMTCT and VMMC 
programs to provide accurate information, dispel myths and misperceptions, and increase 
acceptability, especially among men. 
Facility level 
Barrier 3: Health provider bias against female condoms 
Recommended action: Implement mechanisms that encourage PMTCT and VMMC counselors to 
promote female condoms regularly with their clients, such as sensitizing county/district 
management teams, implementing refresher trainings, providing continuing medical education 
slides, and equipping counselors with vaginal models to assist with product demonstrations.  
Barrier 4: Difficulty in measuring uptake, which is needed to justify supply  
Recommended action: Improve tracking and documentation of consumption/demand to help build 
adequate supply of female condoms at PMTCT and VMMC sites. 
Government level 
Barrier 5: Lack of political will to implement policies 
Recommended action: Advocate with national and county government officials to implement 
policies and cultivate champions for female condoms and their integration into PMTCT and 
VMMC programs.   
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This assessment found that a supportive policy and systems environment for integrating female condoms 
into PMTCT and VMMC programs does not automatically translate into access on the ground. Barriers to 
integration centered on negative attitudes, misinformation, and biases at multiple interconnected levels: 
individuals tend to have low awareness or hold misperceptions about female condoms; health providers at 
the facility level often are not comfortable discussing female condoms with clients, reinforcing low 
awareness and consumption; and government officials do not champion female condoms as they do other 
HIV prevention interventions, in part because of perceived lack of interest or demand from consumers. 
Because female condoms have a higher unit cost than male condoms, this vicious circle weakens the case 
for decision-makers to invest in female condom procurement and distribution through HIV prevention 
programs, resulting in a perpetually limited supply.    
These challenges, however, did not diminish stakeholders’ optimism around female condoms as a 
protection option and their prospective role in PMTCT and VMMC programs. They believed that 
facilities are ready to program female condoms and that PMTCT and VMMC clients and their partners 
are good target audiences with expressed and latent demand. Government officials, program 
implementers, and advocates at the country level must work together to translate policies into practice and 
effect solutions that will expand access to options for lifesaving dual protection.   
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Background 
The importance of integrating family planning (FP) and HIV prevention services in low-resource settings 
is becoming more prominent on the international public health agenda. Such attention is critical given the 
immense health need for contraception and HIV prevention. For example, 222 million women in 
developing countries who wish to avoid a pregnancy have an unmet need for contraceptives.
1
 In 2012, an 
estimated 35.3 million people were living with HIV, and 2.3 million people became newly infected—the 
majority through sexual transmission.
2
 HIV is the leading cause of death and disability among women of 
reproductive age globally.
3
  
Linking FP and HIV prevention at the policy, operational, and service-delivery levels has the potential to 
improve health outcomes and reduce costs. A systematic review of the literature on linking sexual and 
reproductive health with HIV prevention found such linkages were considered beneficial and feasible, 
especially in FP clinics, HIV counseling and testing centers, and HIV clinics.4 While the implementation 
of integrated programs varies across communities, the anticipated benefits are similar: improved access to 
and uptake of FP and HIV services, expanded coverage for underserved populations, and greater 
promotion of dual protection from unintended pregnancies and HIV and other sexually transmitted 
infections (STIs).
5
  
Female condoms
a
 present a unique opportunity to link FP and HIV prevention for women and men at risk 
of HIV/STI infection and unintended pregnancy. Female condoms are the only technology currently 
available that provides woman-initiated dual protection, and they are an attractive method to couples for 
many reasons. Female condoms give women a tangible opportunity to negotiate for safer sex, which is 
particularly crucial when male partners cannot or will not use male condoms. They have features that may 
be more appealing than male condoms, like a looser fit that does not constrict the penis. They also do not 
contain hormones or have systemic side effects, which women with unmet need report are among the 
main reasons that they do not use a modern contraceptive method.
6
  
Many global health strategies and frameworks encourage promotion of both male and female condoms as 
part of an evidence-based, comprehensive approach to HIV prevention.
7-9 
Indeed, evidence suggests that 
including female condoms in well-planned prevention programs may contribute to benefits like cost-
savings and improved sexual and reproductive health. Several models have shown the cost-effectiveness 
of female condoms when compared to the costs of HIV treatment,
10-13
 and when male condom use is not 
possible.
14
 Studies in several countries have found that levels of protected sex increase when female 
condoms are added to the method mix, potentially reducing the risk of HIV infection and unintended 
pregnancies.
15-22
 
 
                                                 
a In this report, “female condom” generally refers to the product manufactured by the Female Health Company (FHC). The “FC1” female 
condom was launched on the market in 1992. Production of the FC1 ceased in 2009 after the FHC’s second-generation “FC2” female condom 
received US Food and Drug Administration approval. The FC2 female condom is the same design as the FC1, but is made with a different 
material that allows for lower manufacturing cost. 
5 
 
Yet in most HIV prevention programs being implemented at the country level, condom promotion and 
distribution focus largely on male condoms. Male condoms are widely available from a variety of public- 
and private-sector sources at no or low cost. They have been supported through behavior change 
strategies and mainstreamed into health facilities over the course of the AIDS epidemic. However, even 
with this supportive environment, male condom promotion and distribution have not been sufficient to 
reduce new HIV and STI infections, particularly among women, who make up nearly 60 percent of adults 
living with HIV in sub-Saharan Africa.
2
  
Integrating female condom promotion and distribution into HIV-prevention programs would strengthen 
awareness and expand access for both women and men in need of dual protection methods beyond male 
condoms.
23
 In recent years, prevention of mother-to-child transmission of HIV (PMTCT) and voluntary 
medical male circumcision (VMMC) have gained significant momentum and political support as effective 
HIV-prevention programs with the capacity to deliver a broader set of FP/reproductive health (RH) and 
HIV services. PMTCT and VMMC programs provide a critical opportunity to examine the extent to 
which existing channels and resources are being leveraged to promote and distribute female condoms 
within HIV-prevention interventions at the programmatic level.  
In 2013, PATH undertook a qualitative assessment in Kenya to explore the opportunities and challenges 
to integrate female condoms in PMTCT and VMMC programs and to identify strategies to help improve 
integration and access in future programming. This report examines the factors that have supported and 
hindered the inclusion of female condoms in these programs and offers potential actions to enhance 
integration.  
PMTCT and VMMC: Platforms for female condom integration   
PMTCT 
Although global scale-up of PMTCT has been an international priority for some years, attention was 
reinvigorated by the 2011 launch of the Global Plan Towards the Elimination of New HIV Infections 
Among Children by 2015 and Keeping Their Mothers Alive,
24
 as well as the 2012 release of the PEPFAR 
Blueprint: Creating an AIDS-free Generation.
25
 PMTCT refers to a set of antenatal, intrapartum (labor 
and delivery), and postnatal/postpartum services that are typically incorporated into maternal and child 
health (MCH) care, which aim to prevent HIV infection among women, infants, and young children and 
to keep mothers alive. The traditional “PMTCT cascade” of services includes voluntary counseling and 
testing for HIV, antiretroviral prophylaxis to reduce the risk of mothers transmitting HIV to their infants, 
HIV testing of exposed infants, counseling on infant feeding, and linkages to HIV care and support. 
Historically, PMTCT programs have been conceptualized and implemented as the set of services in the 
PMTCT cascade (see Figure 1), rather than a broader set of prevention, treatment, and care services.
26
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Recent scale-up efforts focus on more comprehensive PMTCT services and espouse the four-pronged 
strategy developed by the World Health Organization shown below in Figure 1:  
• Primary prevention of HIV among women of reproductive age.  
• Prevention of unintended pregnancies among women living with HIV. 
• Prevention of HIV transmission from mother to child. 
• Ongoing care, treatment, and support to mothers living with HIV, their children, and families. 
Figure 1. The four-pronged PMTCT strategy and the PMTCT cascade. 
 
Global policies reflect that female condoms play an important role in comprehensive PMTCT 
programming, as demonstrated in Table 1. 
Table 1. Female condoms in global PMTCT policies. 
Policy/guidance document Language on PMTCT and female condoms 
Guidance on Global Scale-Up of the Prevention of 
Mother-to-Child Transmission of HIV (WHO/UNICEF; 
2007)27 
 Package of routine quality antenatal and postpartum care 
for all women regardless of HIV status should include 
“provision and promotion of male and female condoms.”  
Preventing HIV and Unintended Pregnancies: 
Strategic Framework 2011 – 2015  
(UNFPA; 2012)28 
 Prong 1 package of essential services includes “condom 
(male and female) promotion, provision and building skills 
for negotiation and use.” 
 Prong 2 package of essential services includes rights-based 
family planning counseling and services that promote “dual 
protection (female and male condoms) and lubricant.” 
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Policy/guidance document Language on PMTCT and female condoms 
PEPFAR Blueprint: Creating an AIDS-Free Generation 
(PEPFAR; 2012)25 
 For Prong 1, the US President’s Emergency Plan For AIDS 
Relief (PEPFAR) will support investment in high-impact, 
evidence-based strategies to prevent HIV infection among 
women of childbearing age, such as “condom provision 
and promotion, including female condoms, supported by 
risk reduction counseling and coaching on condom 
negotiation.” 
VMMC 
Countries that have high rates of HIV and low rates of male circumcision have been rapidly scaling up 
VMMC services since results from three randomized controlled trials showed that VMMC reduces 
heterosexual HIV acquisition in men by up to 60 percent.
29,30
 VMMC refers to the surgical removal of all 
or part of the foreskin by a trained medical provider. This helps to prevent HIV acquisition since the inner 
aspect of the foreskin is highly susceptible to HIV infection.
31
 Initial scale-up has targeted adolescent and 
adult men through static, mobile, and outreach channels. VMMC is widely regarded to be an important 
part of a comprehensive approach to prevent HIV infection, as well as an opportunity to reach men with 
sexual and reproductive health information and services beyond the surgical procedure.
32
 This is 
important because the circumcision procedure is only partially protective against HIV, meaning that 
correct and consistent condom use is still needed.
33
  
As with PMTCT, global policies reflect the importance of female condom promotion within the VMMC 
setup, as shown in Table 2. 
Table 2. Female condoms in global VMMC policies. 
Policy/guidance document Language on VMMC and female condoms  
Operational Guidance for Scaling up Male Circumcision 
Services for HIV Prevention (WHO, UNAIDS; 2008)34 
Minimum package for male circumcision services includes:  
 HIV testing and counseling 
 Screening and treatment for STIs 
 Provision and promotion of male and female condoms 
 Counseling on risk reduction and safer sex  
 Male circumcision surgical procedure 
PEPFAR’s Best Practices for Voluntary Medical Male 
Circumcision Site Operations (OGAC; 2013)35 
 Checklist for pre-operative VMMC counseling includes 
“demonstration of male and female condoms, unless 
client is too young.” 
 Checklist for post-operative VMMC counseling includes 
distribution of “male and female condoms for use once 
[patient] re-engages in sexual activity in six weeks after 
the date of VMMC surgery.”  
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Kenya: A case example to explore how policy meets program  
Rationale for Kenya 
The overall objectives of PATH’s qualitative assessment were to explore the opportunities and challenges 
to integrate female condoms into PMTCT and VMMC programs for HIV prevention, and to identify 
strategies to help improve integration and access in future programming. PATH conducted field work in 
Kenya to determine to what extent female condom counseling and distribution are included in PMTCT 
and VMMC programs in practice, and to explore perspectives at the policy, program management, and 
frontline implementation levels to understand factors affecting access. PATH selected Kenya because it 
offers a plausible environment for integration, which includes established PMTCT and VMMC programs, 
supportive national policies and guidelines, some female condom distribution, and significant health need 
(Table 3). 
Table 3. Kenya and female condom integration landscape at-a-glance.  
Integration factors Description 
PMTCT program  National program initiated in 2002, with substantial scale-up since 
then. 
 Today more than 80% of all pregnant women receive PMTCT services 
at more than 5,000 PMTCT sites across the country.36  
VMMC program  National program launched in 2008, now mainstreamed into annual 
MOH health planning.37 Initial service delivery in Nyanza, Western, 
Rift Valley, and Nairobi provinces.  
 By 2010, medical circumcision services were available at 268 facilities 
in the target provinces.38 The proportion of men circumcised 
increased from 85% in 2007 to 91% in 2012, with the largest increase 
in Nyanza (48% to 66%).39  
Policies and guidelines supporting female 
condom integration 
PMTCT 
 National PMTCT operational guidelines emphasize the need to 
strengthen linkages to FP services and condom access for dual 
protection, and explicitly call for counseling on female condoms.36 
 National 10-day course for health care workers on PMTCT theory and 
practice includes female condoms as a strategy for dual protection in 
a unit on FP.40  
VMMC 
 National VMMC strategy41 and communication strategy42 both state 
that VMMC needs to be integrated with sexual and reproductive 
health services, and call for provision and promotion of “condoms.”b  
HIV/AIDS  
 Implementation plan for the Kenya National AIDS Strategic Plan 
2009/10–2012/13 highlights “increased demand and use of female 
condoms” as a key output, and recommends that they be promoted 
among couples for dual protection.43  
                                                 
b Whereas Kenya’s PMTCT policies and guidelines explicitly support including female condoms, VMMC national policies only refer to 
“condoms.” 
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Integration factors Description 
Sexual and Reproductive Health-HIV integration  
 The 2009 National Reproductive Health and HIV and AIDS Integration 
Strategy contains objectives to strengthen the policy environment, 
ensure adequate financial resources, build capacity for service 
provision, and strengthen supply chain management systems for 
integrated RH and HIV services at all levels. The minimum RH-HIV 
package that guides implementers at all levels of care features 
“condoms” prominently throughout.44 
Female condom distribution  Female condoms are available through the public sector on a limited 
basis, targeted mainly to most-at-risk populations. From 2010–2013, 
3.8 million female condoms were supplied by international donors to 
the government of Kenya for free distribution through the public 
sector.45   
Health need HIV infections 
 In 2012, 5.6% of adults (1.192 million) aged 15 to 64 years were living 
with HIV, with a higher proportion of women (6.9%) affected than 
men.39  
 Most new HIV infections occur in couples who engage in sexual 
intercourse within a union or regular partnership.46 
Unmet need for family planning 
 Approximately 26% of women aged 15 to 49 years who are married 
or in a union have an unmet need for FP.47  
Methodology  
PATH used qualitative methods to collect and analyze information. Through desk research, PATH 
explored the programmatic and policy landscape for PMTCT and VMMC in Kenya and identified the key 
individuals, organizations, agencies, and programs involved in delivering these services. We then 
conducted five telephone interviews with representatives from international nongovernmental 
organizations and agencies involved in policy and program implementation to validate preliminary 
findings from the desk research. Ethics approval for the qualitative assessment was received in September 
2013 from the Kenya National Commission for Science, Technology, and Innovation. 
In October 2013, PATH conducted an additional 17 face-to-face interviews with policymakers, 
international aid officials, service providers, and advocates in Nairobi and Nyanza (see Table 4). Four of 
these interviews took place at a health facility or involved a facility tour (one in Nairobi, three in Nyanza). 
Interviews were conducted in Nairobi and Nyanza because PMTCT and VMMC policymakers and 
program implementers are clustered there. Nairobi is the seat of the national government and home to the 
headquarter offices of many international health organizations involved in PMTCT and VMMC. Nyanza 
is a focus region for VMMC scale-up; it is cited as one of the few regions that has made significant 
progress in expanding VMMC services among the 13 countries engaged in VMMC scale-up.
14 
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Table 4. Breakdown of stakeholder interviews.  
Stakeholder group Nairobi Nyanza Total 
National policymakers 1 - 1 
Multilateral and bilateral aid agencies 2 1 3 
Service providers 3 5 8 
Reproductive health and HIV advocacy groups 4 1 5 
Total 10 7 17 
 
PATH developed interview guides for the different stakeholder groups to elicit opinions and generate 
discussion. Topics addressed included perceptions of the role of female condoms as an option for 
contraception and STI/HIV prevention; perceived need or value for clients accessing PMTCT/VMMC 
services to receive female condom counseling and supplies; feasibility, opportunities, and challenges of 
integrating female condom promotion and provision into PMTCT and VMMC programs; and potential 
strategies to improve integration. Interviews were scheduled for approximately 60 minutes and were 
conducted by PATH staff in English. PATH obtained verbal consent from each stakeholder to participate 
in the interview during the scheduling process, and verbal permission to audio record the discussion at the 
beginning of each interview. PATH staff analyzed the interview notes and performed manual coding for 
themes. Audio recordings were used to revisit and transcribe direct quotes that illustrated key themes.  
Key findings 
Stakeholder interviews confirmed PATH’s preliminary findings from desk research and telephone 
interviews that female condoms are not regularly available for distribution at PMTCT and VMMC sites in 
Kenya. Only one out of the four facilities that PATH visited had female condoms available for 
distribution. Despite this lack of availability, all stakeholders were familiar with the product, and most 
believed it offered numerous advantages. They acknowledged the value of female condoms for STI/HIV 
prevention, family planning, dual protection, women’s empowerment, and for instances when men do not 
or cannot wear male condoms. For example, according to an HIV/AIDS official at a bilateral aid agency:  
The role of female condoms is very crucial. We know it helps in the prevention of STIs, including 
HIV, and also pregnancies. It comes in handy in special situations. For example, men who get 
drunk—it inhibits them from taking preventative measures such as [male] condoms. So when that 
situation arises, if a woman has a female condom, then that is very good to protect her.  
—Nyanza bilateral 03    
Stakeholders highlighted additional benefits of female condom use, particularly for pregnant women and 
sero-discordant couples. They stressed that using condoms during pregnancy would protect the mother 
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and fetus from STIs, and female condoms would offer women an additional tool to negotiate such 
protection. For HIV-positive pregnant women in sero-discordant relationships, the female condom could 
play a crucial role in preventing onward transmission of HIV to her partner. Several stakeholders, 
moreover, expressed the value of female condoms for pregnancy prevention. They stated that female 
condoms should be emphasized further in PMTCT postnatal counseling sessions.  
Stakeholders believed that integrating female condoms into PMTCT and VMMC programs would be 
feasible and beneficial. They described an enabling policy environment and corroborated the fact that 
guidelines, training, and distribution systems that would support the inclusion of female condoms in 
PMTCT and VMMC programs are in place, though some policy gaps remain.
c
 Stakeholders reported that 
female condoms are included in counselor trainings and that female condoms share the same supply chain 
as male condoms; both commodities are furnished to public-sector health facilities by the Kenya Medical 
Supplies Agency, though many more male condoms are supplied than female condoms.  
Adding female condom distribution to PMTCT and VMMC programs would not be difficult. A VMMC 
service provider explained: 
There would be no big problem with distribution at the facilities. Even with the few consignments 
of female condoms that we’ve received, they’ve been distributed. … Within a short time they are 
gone. I strongly believe [it would be beneficial] if we could make these female condoms available 
and channel them through the normal distribution channels of the ministry. 
—Nyanza service provider 06  
This sentiment was echoed by a not-for-profit provider in Nairobi:  
It would be a good entry point [to have female condoms integrated into PMTCT and VMMC 
programs] because the stage is already set when you are doing the counseling and giving 
options. It is an add-on to the package.  
— Nairobi service provider 03 
In spite of this supportive environment, stakeholders identified numerous challenges to integration, all of 
which are the same as those faced in female condom programming in general. The foremost challenge is 
the absence of female condoms in public-sector health facilities or retail channels; integration cannot 
happen without the product itself. Stakeholders reported that in many facilities, female condoms are 
available “for demonstration only,” meaning that the facility might have a couple of pieces for display but 
none for distribution. Many stakeholders pointed to the relatively high cost of female condom 
commodities to the national government—particularly when compared to male condoms—as a main 
driver of low availability in the public sector. 
                                                 
c Some of Kenya’s national policies on RH and HIV/AIDS integration and VMMC refer only to “condoms” rather than “male and female 
condoms.” The term “condom” is often implicitly understood as meaning “male condoms.”   
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Stakeholders explained that lack of product availability stems from additional barriers at the individual, 
facility, and government levels. These barriers largely involve negative attitudes and misperceptions that 
stymie demand creation and discourage government officials from recognizing female condoms as a 
critical commodity. The following section elaborates on these barriers and recommends actions at 
different levels that could help address these challenges, foster product availability, and more 
meaningfully integrate female condoms into HIV prevention programs (Figure 2).   
Figure 2. Barriers and recommended actions to support female condom integration. 
Barriers and recommended actions to improve integration  
Individual level 
Barrier 1: Low awareness among women and men 
Even though all stakeholders interviewed were familiar with female condoms, they remarked that the 
general population is still largely uninformed about female condoms. Several stakeholders mentioned that 
health facilities and marketers have not given out sufficient messaging and promotional materials. 
Sensitization is needed for female condoms to be on the same level as male condoms, so that it is 
no longer this “mystical thing” [for women and couples].  
—Nairobi bilateral 01  
The information about female condoms is not out there yet. It is rare to find a young man 
discussing female condoms.  
—Nairobi advocacy group 04 
13 
 
Recommended action: Leverage VMMC programs as an untapped platform to reach men and their 
female family members with female condom promotion.  
Whereas Kenya’s PMTCT policies and guidelines explicitly support including female condoms, VMMC 
national policies only refer to “condoms.” Stakeholder interviews revealed that female condom 
integration into VMMC programs has not been fully explored or embraced; this represents an avenue 
through which to increase awareness of the method among target audiences.  
Some stakeholders felt that integrating female condoms into VMMC programs would be a useful strategy 
to reach men, and many more thought that it would be a novel and effective opportunity to reach women. 
Both HIV-negative and HIV-positive men are turning out for VMMC—and many are sexually active—
underscoring the importance of HIV prevention messaging and the role that female condoms could play 
in protecting them and their partners. A VMMC service provider predicted that female condoms would be 
well-received by men if adequate education and promotion were provided:  
If health education on the importance of female condoms can be strengthened within the VMMC 
setup, then there would be increased uptake even among the males. If we can have a way in which 
males can be convinced and properly educated on the importance of female condoms, then yes, 
male and female condoms will be well-accepted at the same time.  
—Nyanza service provider 08 
A number of stakeholders saw female condom integration into VMMC programs as a great way to reach 
women. They described how women are adept at mobilizing their husbands, partners, and/or sons to get 
circumcised and often accompany them to the procedure. VMMC settings, therefore, provide a platform 
to sensitize women about female condoms. 
There are a number of females who normally come with their partners for testing and VMMC 
services. So if we can station female condoms within the VMMC and counseling rooms, then that 
can also be one of the areas to target to get a number of females.  
—Nyanza service provider 05 
We need availability of female condoms within the VMMC setup. We are currently using females 
as mobilizers and peer educators. Most counselors in the VMMC setup are also females. Part of 
what these female peer educators and counselors do is convince the men to use condoms and to 
bring their wives to the procedure. At this point, we can get their wives and girlfriends and talk to 
them about the importance of female condoms.  
—Nyanza service provider 08 
If a mother brought her boy, that would be a good opportunity to talk to her. Yes, the VMMC 
setting presents a good opportunity.  
—Nyanza bilateral 03 
14 
 
None of the stakeholders interviewed spoke of existing efforts to target women attending VMMC with 
female condom promotion. VMMC settings present an untapped opportunity to explore.  
Barrier 2: Product misperceptions and resistance among men  
Myths and misperceptions about female condoms are common among women and men familiar with the 
product. Most stakeholders raised some combination of the following complaints from clients: female 
condoms make a lot of noise (“Sounds like a plastic bag”); the condom is too big (“When you bring out a 
female condom [your client] is like, ‘Ah! That is too big!’”); women are required to insert the female 
condom many hours before sex for it to work properly (“Women have to put it on hours before sex, while 
men use male condoms at the right time”). None of these are true of the product available in Kenya (the 
FC2), yet these concerns have become popular myths that have detracted from acceptability. Moreover, 
stakeholders said that men hold unfavorable views of the female condom and its use; this sometimes 
stems from myths and misperceptions. 
For men, the female condom does not look appealing.  
—Nairobi advocacy group 02 
[Men] prefer male condoms. In African society, the man tends to enjoy quite a command. They 
prefer using what they have control over [like male condoms].  
—Nyanza service provider 05 
We have given men female condoms but have heard complaints that they do not trust the product. 
—Nairobi advocacy group 04 
Recommended action: Take advantage of the couples-counseling setting in PMTCT and VMMC 
programs to provide accurate information, dispel myths and misperceptions, and increase 
acceptability, especially among men. 
PMTCT and VMMC programs emphasize partner involvement and encourage couples to attend 
counseling sessions. Stakeholders felt that program implementers should further capitalize on PMTCT 
and VMMC couples-counseling to improve knowledge and acceptability and contribute to increased 
levels of correct and consistent use. High-quality counseling, furthermore, can address the 
aforementioned myths and misperceptions about female condoms that may negatively affect an 
individual’s willingness to try the product.  
A PMTCT service provider underscored why it is important to counsel on female condoms in a setting 
with the couple present:  
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Women [seeking PMTCT services] sometimes come without their male partners for HIV testing. 
It is challenging to introduce a female condom [only] to a woman because she needs to go home 
and explain it to her male partner. Remember, male condoms are not properly used at home 
either…because male partners are a bit resistant to condom use. So when you introduce a female 
condom without a male counterpart, it brings out a [heated] discussion in the family. … The 
women fear taking the female condom home.  
—Nyanza service provider 07 
Historically, male involvement in the PMTCT continuum of care has been low in Kenya. For example, 
less than 30 percent of pregnant women were tested for HIV together with their partners in 2009.
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However, many organizations are implementing innovative approaches to increase male participation, 
such as priority status and shorter wait times for couples.
49
 Providing counseling on female condoms in 
instances where couples turn out for PMTCT HIV testing and counseling can help facilitate condom use. 
According to a PMTCT mentor mother: 
We like men to come on board because when they are tested together, it’s more likely for this 
couple to be counseled together and use condoms effectively. 
—Nairobi advocacy group 02 
Couples counseling, furthermore, can help create a safe space for a woman to disclose her HIV-positive 
status to her husband or partner—a step considered by stakeholders to be fundamental to successful and 
sustained condom use.  
Couples-counseling at VMMC sites was also viewed as a promising strategy for female condom 
promotion.  
Quite a number of women attend those VMMC clinics. They come with their spouse, and it’s a 
very good opportunity to counsel both of them on the use of the female condom. 
—Nyanza service provider 04 
Several stakeholders explicitly preferred discussing female condoms within a couples setting rather than 
an individual setting with men. They believed that the female condom is understood to be a “woman’s 
product;” thus, a man might not be receptive to female condom counseling unless his partner is present. 
According to a VMMC national policymaker: 
Whenever you talk about condoms, male or female, your client is basically the man. Unless you 
have a couple [with whom] you can talk about the female condom, it is hard to promote the 
female condom to men. 
—Nairobi policymaker 01   
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A VMMC service provider in Nyanza confirmed that the VMMC initiatives that his program supports 
have a specially designed counseling protocol for couples that includes messages on why it is important 
to use male and female condoms as a couple—including for family planning. He also said that there is 
[male] condom uptake after these sessions (Nyanza service provider 06).  
Decades of experience with female condom programming has shown that health care provider interaction 
and counseling play a critical role in influencing women and men to initiate and maintain use of the 
product.
50
 Couples counseling may play a particularly important role in PMTCT and VMMC programs.  
Facility level 
Barrier 3: Health provider bias against female condoms 
Although stakeholders reported that information about female condoms is included in trainings for 
PMTCT and VMMC counselors, and that couples counseling could potentially be a great avenue for 
increasing awareness and acceptability, they indicated that providers are sometimes reluctant to discuss 
the method. Providers’ familiarity with male condoms, as well as their discomfort with/bias against 
female condoms, were common explanations.    
When a client asks for a condom, the first thing that is the health worker’s perception is [that the 
client is asking for] the male condom, not the female condom. It is easier for health workers to 
explain about the male condom rather than the female condom.  
—Nairobi multilateral 02 
A lot of [peer educators] are more comfortable demonstrating the male condom, because it is 
always in use, everybody talks about it, everybody sees it. But with the female condom there is a 
bit more restraint.  
—Nairobi service provider 01 
In the [health] facility, we need to change the way we clinicians perceive the female condoms. To 
me, I think we just mention them but we are not taking steps so they are demanded. We need to 
talk to the clinicians themselves to embrace the female condom and have [discussions about it] as 
a routine health talk.  
—Nyanza service provider 05 
Recommended action: Implement mechanisms that encourage PMTCT and VMMC counselors to 
promote female condoms with their clients regularly, such as sensitizing county/district 
management teams, implementing refresher trainings, providing continuing medical education 
slides, and equipping counselors with vaginal models. 
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Stakeholders identified several opportunities to address health provider bias and to strengthen the quality 
and consistency of female condom counseling in PMTCT and VMMC programs, and at the facility level 
more broadly:  
• Encourage health management teams at the county/district level to prioritize female condom 
programming. Kenya’s 2010 constitution initiated the devolution of health care to the county level. 
County officials are now responsible for community and primary health care services, so their support 
for female condoms would help set the tone at the facility level. 
If a form of general education and capacity-building can be done with district health 
management and facility health management teams to understand the importance of female 
condoms, I’m very sure the uptake, acceptance, and requests for female condoms would also 
increase.  
—Nyanza service provider 08 
Another VMMC service provider affirmed this approach:  
The best people to champion [the female condom] are at the district level.  
—Nyanza service provider 06 
• Implement female condom education initiatives. Stakeholders recommended female condom 
refresher trainings among providers and lay counselors. One PMTCT stakeholder suggested the 
preparation of continuing medical education slides to reinforce learning among medical professionals, 
as well as training of peer educators because they know the health care system and the right people to 
with whom to interact. 
• Equip counselors with vaginal models so that both the counselor and client would be more confident 
in discussing use. A service provider at an MCH/HIV integrated facility in Nyanza explained:  
We have models for male condom demonstrations that we use when we tell clients how to use the 
product. With female condoms, we don’t. So that brings the question of how we pass the message 
to clients. At the end of the day, they don’t believe in it. If we can have models for female condom 
demonstrations, it can become easier.  
—Nyanza service provider 07 
Barrier 4: Difficulty measuring uptake, which is needed to justify supply  
Lack of reliable supply at the facility level is another reason that underlies PMTCT and VMMC 
providers’ reluctance to promote female condoms. Several stakeholders were concerned about creating 
demand for a product that is often unavailable: 
We are not comfortable discussing the female condom sometimes. Why? Before, we’ve created 
demand and then there were stock-outs. So after you create all the demand and the client needs it, 
you cannot supply it. And then you have raised all these expectations. 
—Nairobi service provider 03 
Stakeholders indicated that providers tend to deal with the female condom counseling/supply issue in one 
of three ways: They 1) skip female condom counseling altogether; 2) counsel about female condoms only 
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when they are in stock; or 3) adjust the counseling to raising awareness that the product exists, rather than 
creating expectations of regular access. These solutions sanction limited product availability as the norm. 
Recognizing this, some stakeholders suggested improving the tracking of female condom consumption to 
facilitate more consistency in the supply from the national government, as well as in access to female 
condoms. 
Stakeholders reported that public-sector health facilities (in which PMTCT and VMMC services are 
typically embedded), as well as nonprofit organizations, receive their commodities from the Kenya 
Medical Supplies Agency. Here, a “pull system” is in place, meaning that the government will supply 
commodities based on actual consumption. This system tends to set up a stalemate pattern for female 
condom distribution: Providers are reluctant to counsel about female condoms, so the product sits on 
shelves. Because consumption is low, the government does not send many supplies to the facilities. This 
situation makes it difficult to have trend data on consumption that could be used for forecasting.  
Another complicating factor for making female condoms consistently available through PMTCT and 
VMMC programs is that consumption is not systematically tracked at the service delivery outlet level.  
The consumption of [female and male] condoms is just like other family planning commodities; it 
is not disaggregated. We only say, “We’ve used 10 million condoms in our health facilities.” 
Whether you’ve used them in the PMTCT setup for family planning or just for STIs, it is not easy 
to know. We do not have that data. … The tracking is an area that could be a gap. 
—Nairobi multilateral 02  
Recommended action: Improve tracking and documentation of consumption/demand to help build 
adequate supply of female condoms at PMTCT and VMMC sites. 
While there is no silver bullet solution to the supply-demand conundrum that affects product integration 
into PMTCT and VMMC programs, there may be ways to improve tracking and communication with 
county and central government officials. A few stakeholders noted that when supply is available and 
counselors promote it, uptake is good.  
Women are asking about female condoms through MCH/PMTCT sites. … We’ve actually had a 
few consignments, and each time they land in the facility, they go like hot cakes. The demand is 
actually existent. 
—Nairobi service provider 02 
The issue is that this indication of demand does not appear to be communicated effectively to the relevant 
government officials with decision-making authority around procurement. A field coordinator with a 
women’s HIV/AIDS group emphasized how difficult it is to document demand for advocacy purposes:  
What fails us most as community workers is documentation. If you go and tell the government 
that I have many women who want female condoms, then they will ask me, “How many? Which 
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age group? What are their names? What is their locality?” If that is not documented, the 
government will turn you away. We are failing on documentation. 
—Nairobi advocacy group 01   
One approach for improving documentation would be for PMTCT and VMMC program managers, as 
well as advocates, to liaise with officials to discuss appropriate ways of documenting female condom 
consumption and demand—especially in the face of supply shortages. This can serve as a basis of 
discussion for future investment. Another strategy may be necessary in cases where it is unrealistic or 
burdensome to add female condom distribution indicators to PMTCT and VMMC data collection 
systems. One such strategy would be to analyze the consumption and demand forecasting processes for 
other new and underutilized family planning methods that have been integrated at the facility level 
successfully. Ultimately, stakeholders felt that systems are in place to receive and distribute female 
condoms and that the critical issue is to find mechanisms to ensure a sustainable supply. 
Government level 
Barrier 5: Lack of political will to implement policies  
While stakeholders unanimously voiced that existing policies support female condom programming and 
integration into PMTCT and VMMC services, they pointed to a lack of political will among national 
government officials to fully implement these policies. Stakeholders believed that this weak commitment 
stemmed from the high unit cost of the female condom compared to male condoms (“The cost of the 
female condom is too high”); negative attitudes about the product (“Admittedly there are some biases 
against female condoms at the top”); and perceived lack of demand (“Nobody wants to use it”). A 
VMMC service provider described how the government has been a champion for a number of health 
interventions but not yet for female condoms: 
[This] might be due to seeming lack of demand. If there is no demand, the government cannot 
procure something that would be at their loss. So the vicious circle goes round and round. We 
need to identify at which level we start—top or bottom? 
—Nyanza service provider 05 
Recommended action: Advocate with national and county government officials to implement 
policies and cultivate champions for female condom programming.  
Many stakeholders thought that greater leadership from the national government, coupled with 
commitment from the county level, could galvanize female condom programming.  
If we have the government, the Minster of Health, and the county level consistently speaking 
about female condoms, it cascades down. It’s about giving it urgency. I believe it can work. We 
have not yet had a champion spearheading female condoms. 
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—Nyanza service provider 05 
A VMMC service provider thought the female condom stakeholders could learn from the successful 
advocacy efforts that helped to catalyze VMMC scale-up in Kenya:  
If the system that was used in implementing VMMC in the last five years could be used in 
implementing female condoms…that would be great. [For example], there must be a strong lobby 
from the implementing partners and from government. … Those who lobbied the government 
went through parliament to adopt VMMC as one of the effective strategies of HIV prevention. The 
opinion leaders and community gatekeepers must have a good perception of female condoms. 
—Nyanza service provider 08  
Many stakeholders mentioned that Kenya’s former Prime Minister Raila Odinga spoke publicly in favor 
of VMMC, which made a difference in persuading community leaders and gatekeepers to support scale-
up efforts. 
In addition to cultivating individual policy and political champions, stakeholders offered several ideas to 
increase attention on female condom programming and integration into PMTCT and VMMC: 
• Host gender forums with a female condom component at the community level to reach women, men, 
and county officials.  
• Advocate for greater female condom integration through technical working groups and papers, since 
many PMTCT and VMMC service provision organizations have linkages to these groups.   
• Leverage quarterly meetings between civil society constituencies and the National AIDS Control 
Council to increase awareness about female condoms, disseminate information, and advocate for 
resource mobilization. 
• Show the demand for female condoms through public demonstrations (“advocacy festivals”), and 
organize press conferences to disseminate the message.  
Advocacy for female condom integration would be strengthened by increased coordination and 
communication among interested organizations in Kenya. Data from these interviews suggest that only a 
handful of groups are currently engaged in female condom advocacy. Stakeholders reported that these 
organizations often operate in isolation, so there is no clear advocacy agenda. It may be helpful for these 
groups to link with international organizations that are involved in female condom advocacy, and to 
receive technical assistance on constituency-building and advocacy strategy development, as well as 
potential funding support.  
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Conclusion 
PATH’s qualitative assessment in Kenya underscores that a supportive policy and systems environment 
for female condom integration into PMTCT and VMMC programs does not automatically translate into 
access on the ground. The barriers to integration that were uncovered by this assessment centered on 
negative attitudes, misinformation, and biases at multiple, interconnected levels: individuals tend not to 
have high awareness or accurate information about female condoms; health providers at the facility level 
often are not at ease discussing female condoms with clients, which reinforces low awareness and 
consumption; and government officials do not champion female condoms like they do other HIV 
prevention interventions, in part because of perceived lack of interest/demand from consumers. Because 
female condoms have a higher unit cost than male condoms, this vicious circle weakens the case for 
decision-makers to invest in female condom procurement and distribution through HIV prevention 
programs.  
These female condom programming challenges are not new and have been previously documented in 
Kenya and other countries around the world. For example, the Population Council conducted a study on 
the feasibility and acceptability of female condom inclusion in HIV voluntary counseling and testing 
(VCT) centers, FP/RH sites, and workplace HIV/AIDS education programs in urban Kenya. It found that 
women and men in the study were largely unfamiliar with the female condom, some men were not 
comfortable with the product as a “woman-initiated” device, peer educators had persistent gaps in 
knowledge even after training, and ineffective logistics systems were common.
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 Another study analyzing 
female condom promotion in VCT centers reported negative perceptions of the female condom among 
clients and counselors. VCT counselors said most of the individuals they counseled believed female 
condoms were “not as good” as male condoms, and the counselors themselves did not seem comfortable 
handling or discussing the female condom.
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 Numerous global analyses of female condom programming 
point to bias and a lack of commitment from national governments and international donors and 
policymakers as the chief obstacles to acceptability at the individual level.
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These challenges, however, did not diminish stakeholders’ optimism around female condoms as a 
protection option and their prospective role in PMTCT and VMMC programs. Stakeholders appreciated 
that female condoms give women and couples another option for dual protection. They underscored that 
many men are resistant to male condom use, so expanding access to female condoms could potentially 
protect sexual partners who would otherwise go unprotected. They believed that facilities are ready to 
program female condoms and that PMTCT and VMMC clients and their partners are good target 
audiences with expressed and latent demand. Stakeholders expressed hope that new female products 
coming to market might be lower-cost or more acceptable, which would help bolster availability and 
uptake.   
Stakeholders largely felt that female condoms are “an opportunity yet to be tapped” and that the future is 
bright for their integration into HIV prevention programs. Acting to address the barriers highlighted in 
this report would help make strides toward greater availability; this could surmount acceptability issues 
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among individuals and providers and create the demand needed to make the case for national 
commitment. It is now up to government officials, program implementers, and advocates at the country 
level to work together to translate these positive perspectives and policies into practice.  
Limitations 
The qualitative assessment faced some limitations. Due to scheduling conflicts, only one interview with a 
national government official was conducted, so this perspective is underrepresented. However, because 
national government officials are charged with developing and executing policy and the policy 
environment for female condom integration in Kenya is already mostly supportive, this 
underrepresentation probably does not significantly affect our findings. In addition, no interviews with 
county-level government officials were conducted. It would be valuable to elicit their perspectives in the 
future given the ongoing devolution of health budgets and oversight. Finally, it is possible that some 
stakeholders expressed bias in favor of female condoms, given PATH’s work to develop and introduce 
the Woman’s Condom, a new female condom design, as well as to advocate for the entire class of the 
product. We addressed this potential bias by asking questions in a neutral manner and probing specifically 
on challenges associated with female condoms.   
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